ÑÇÖÞAV

ÑÇÖÞAV is poised to be named a managing member in the Cybersecurity Manufacturing Innovation Institute (CyManII), a $111 million public-private partnership led by the University of Texas at San Antonio.

A team of researchers from ÑÇÖÞAV will lead efforts to develop a dynamic, high-performance programmable Cyber-Infrastructure testbed that connects research communities and their resources in the United States with collaborating partners and facilities in Europe

Bioengineering professor Siddhartha Sikdar is using technology to help individuals with limb loss better control their prostheses.

A urine-based Lyme disease test created by a team of ÑÇÖÞAV researchers could soon become available statewide after a recent clinical validation study confirmed that it meets sensitivity and absolute molecular specificity standards.

Faculty members Holly Matto, Padmanabhan Seshaiyer, Stephanie Carmack, and Nathalia Peixoto, and graduate student Matthew Scherbel, are working with Brightline Interactive to examine the effects of recovery cues, using virtual reality simulations, on neurophysiological regulation to prevent drug relapse.

ÑÇÖÞAV anticipates reporting more than $200 million in sponsored research expenditures for fiscal year 2020, which would be an all-time high for the university and shows significant progress toward the university’s strategic goal of $225 million by 2024.